A L Kovalenko Selected Research

10-carboxymethyl-9-acridanone

1/2017	[Clinical efficacy of the immunomodulatory agent cycloferon (tablets) in viral respiratory infections: Results of a systematic review and meta-analysis].
1/2014	[The influence of immunotropic drugs on reparative processes in the lungs experimental chemotherapy drug resistant tuberculosis].
1/2014	[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers].
1/2013	[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses].
1/2013	[Cycloferon in complex therapy management of chronic laryngitis].
1/2013	[Immunotropic and antihypoxant therapy of experimental drug-sensitive and drug-resistant tuberculosis].
1/2013	[Cycloferon as an agent for the anti-relapse therapy in patients with chronic hyperplastic sinusitis].
1/2013	[Virus infections and interferon inducers in the complex therapy].
1/2012	[Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever].
1/2012	[Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A L Kovalenko Research Topics

Disease

10	Infections 01/2016 - 01/2000
8	Virus Diseases (Viral Diseases) 01/2017 - 11/2004
8	Tuberculosis (Tuberculoses) 01/2014 - 01/2008
7	Human Influenza (Influenza) 01/2014 - 09/2000
6	Poisoning 01/2018 - 07/2001
5	Diabetic Foot 01/2018 - 01/2014
5	Cholestasis 01/2016 - 01/2010
5	Brain Ischemia (Cerebral Ischemia) 01/2015 - 04/2004
5	Chronic Hepatitis C 01/2013 - 01/2010
5	Neoplasms (Cancer) 01/2013 - 01/2000
4	Ischemic Stroke 01/2020 - 01/2014
4	Disease Progression 01/2018 - 01/2015
4	Hypoxia (Hypoxemia) 01/2018 - 01/2015
3	Osteochondrosis (Osgood Schlatter Disease) 01/2021 - 01/2017
3	Pneumonia (Pneumonitis) 01/2018 - 01/2009
3	Myocardial Infarction 02/2016 - 01/2002
3	Inflammation (Inflammations) 01/2014 - 01/2000
3	Ischemia 01/2014 - 04/2004
3	Fever (Fevers) 01/2012 - 01/2009
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2011 - 01/2010
3	Chronic Hepatitis B 11/2010 - 01/2010
2	Stroke (Strokes) 01/2020 - 01/2015
2	Polyneuropathies (Polyneuropathy) 01/2017 - 01/2014
2	Wounds and Injuries (Trauma) 01/2017 - 01/2011
2	Body Weight (Weight, Body) 02/2016 - 01/2016
2	Hepatomegaly 01/2016 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2016 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 01/2016
2	Alcoholism (Alcohol Abuse) 01/2015 - 01/2010
2	Brain Infarction 01/2015 - 01/2014
2	Ulcer 01/2015 - 11/2001
2	Hepatitis 01/2014 - 01/2011
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2014 - 01/2013
2	Brucellosis (Malta Fever) 01/2014 - 01/2010
2	Laryngitis 01/2013 - 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Intraoperative Complications 01/2020
1	postintensive care syndrome 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Alcohol Withdrawal Delirium (Delirium Tremens) 01/2016
1	Lymphadenopathy 01/2016
1	Carcinosarcoma 01/2016
1	Hypothyroidism 01/2016
1	Hypoparathyroidism 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Pharyngitis (Sore Throat) 01/2016
1	Hyperthermia 01/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016

Drug/Important Bio-Agent (IBA)

28	10-carboxymethyl-9-acridanoneIBA 01/2017 - 01/2000
27	cytoflavinIBA 01/2021 - 02/2000
21	Pharmaceutical PreparationsIBA 01/2016 - 09/2000
16	RemaxolIBA 01/2017 - 01/2008
10	InterferonsIBA 01/2013 - 01/2000
9	Succinic Acid (Succinate)IBA 01/2016 - 07/2001
9	AntioxidantsIBA 01/2016 - 01/2011
7	ReamberinIBA 01/2018 - 01/2010
6	TabletsIBA 01/2017 - 01/2009
5	SolutionsIBA 01/2016 - 01/2008
5	Antiviral Agents (Antivirals)IBA 01/2012 - 01/2010
4	Ethanol (Ethyl Alcohol)IBA 01/2016 - 07/2001
4	Free RadicalsIBA 01/2015 - 07/2001
3	Immunologic Factors (Immunomodulators)IBA 01/2017 - 01/2010
3	Neuroprotective AgentsIBA 04/2005 - 11/2003
3	NeuronolIBA 09/2004 - 12/2003
2	Urea (Carbamide)FDA LinkGeneric 01/2016 - 01/2015
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2015 - 01/2014
2	Meglumine FDA Link 01/2014 - 01/2011
2	EnzymesIBA 01/2014 - 01/2008
2	Ribavirin (Virazole)FDA LinkGeneric 01/2012 - 01/2012
2	AcidsIBA 01/2011 - 01/2002
2	Therapeutic UsesIBA 11/2010 - 01/2010
2	Saline SolutionIBA 09/2010 - 02/2000
1	barbituric acid (barbiturate)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	PeroxidesIBA 01/2017
1	Phospholipases (Phospholipase)IBA 01/2017
1	Membrane LipidsIBA 01/2017
1	LipidsIBA 01/2016
1	CatalaseIBA 01/2016
1	AlbuminsIBA 01/2016
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Transferrin (beta 2 Transferrin)IBA 01/2016
1	Ferritins (Ferritin)IBA 01/2016
1	Arginine (L-Arginine)FDA Link 01/2016

Therapy/Procedure

40	Therapeutics 01/2021 - 01/2000
5	Drug Therapy (Chemotherapy) 01/2014 - 01/2010
4	Ligation 01/2020 - 09/2010
2	Aftercare (After-Treatment) 01/2017 - 01/2016
2	Length of Stay 01/2016 - 01/2010
2	Critical Care (Surgical Intensive Care) 01/2016 - 07/2001
2	Injections 01/2014 - 01/2002
1	Overlapping Surgery 01/2021
1	Neurological Rehabilitation 01/2020
1	Laparotomy 01/2017
1	Transplantation 02/2016
1	Conservative Treatment 01/2016